A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions

Study Type: Interventional Study Design: A single-dose, open-label, randomized, two-period crossover study Official Title: A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalence Study of Ramipril10 mg Capsules Under Fed Conditions Further study details as provided by Actavis Elizabeth LLC: Primary Outcome Measures: Rate and Extend of Absorption